Hydromorphone is a pure opioid, a semi-synthetic hydrogenated ketone derivative of morphine that has been available clinically since 1920. Structurally, hydromorphone derived from morphine in the modification of the hydroxyl group in the carbon 6 to a carbonyl and the absence of a double bond between the carbon 7 and 8. Due to these modifications, it present...
Hydromorphone is indicated for the management of moderate to severe acute pain and severe chronic pain. Due to its addictive potential and overdose risk, hydromorphone is only prescribed when other first-line treatments have failed.
...
Hamilton Health Sciences, Hamilton, Ontario, Canada
St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada
Duke University Medical Center, Durham, North Carolina, United States
Hartford Hosptial, Hartford, Connecticut, United States
NorthShore University HealthSystem, Evanston, Illinois, United States
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Texas Children't Hospital, Houston, Texas, United States
Vince & Associates Clinical Research, Overland Park, Kansas, United States
Department of Anesthesiology, University Hospital Erlangen, Erlangen, Germany
Rochester Methodist Hospital, Mayo Clinic, Rochester, Minnesota, United States
Duke University Hospital, Durham, North Carolina, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.